PD-Rx Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of PD-Rx Pharmaceuticals generated cash of $1,788,703, which is more than the previous year. Cash used in financing activities reached the amount of -$710 last year. Net change in cash is therefore $1,361,151.
Cash Flow
| 2016 | 1.86M | -589.24K | 0 |
|---|---|---|---|
| 2018 | 421.89K | -484.68K | -1.16M |
| 2020 | -586.53K | 700.26K | 933.7K |
| 2021 | -465.77K | -85.92K | 0 |
| 2023 | 1.78M | -426.84K | -710 |
PDRX Cash Flow Statement (2015 – 2022)
| 2022 | 2020 | 2019 | 2017 | 2015 | |
|---|---|---|---|---|---|
Cash at beginning of period | 5.47M | 3.45M | 2.40M | 5.08M | 3.98M |
Operating activities | |||||
Net income | -98.06K | 1.85M | -384.14K | 621.16K | 507.67K |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 139.05K | 114.63K | 161.02K | 176.54K | 172.00K |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 1.72M | -1.84M | 271.59K | -970.62K | 265.68K |
Inventories | 196.18K | -802.92K | -383.45K | 25.87K | 338.91K |
Accounts payable | 0 | 1.06M | -5.65K | 470.03K | 630.31K |
Cash generated by operating activities | 1.78M | -465.77K | -586.53K | 421.89K | 1.86M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -426.84K | -107.92K | -49.74K | -274.38K | -89.74K |
Acquisitions Net | 0 | 22K | 0 | 39.75K | 500 |
Cash generated by investing activities | -426.84K | -85.92K | 700.26K | -484.68K | -589.24K |
Financing activities | |||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | -1.13M | 0 |
Repurchases of common stock | -710 | 0 | 0 | -29.04K | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -710 | 0 | 933.7K | -1.16M | 0 |
Net Change In Cash | 1.36M | -551.7K | 1.04M | -1.22M | 1.27M |
Cash at end of period | 6.83M | 2.90M | 3.45M | 3.86M | 5.25M |